February 25, 2015 | Vectorious Medical Technologies, a medical device company, announced that it raised $5 million in new funding. Investors in the funding round included RadBioMed incubator and private investors including Zohar Gilon, Gur Muntzer and US-based Global Cardiovascular Innovation Center (GCIC) of the Cleveland Clinic. The company will reportedly use the funds to continue the development of its medical products for the treatment of cardiovascular conditions, with hopes to begin the first human trials together with US and Israeli cardiologists. Vectorious Medical Technologies was founded in 2011 by CEO Oren Goldstein.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments